Clinical Pharmacology Quality Assurance for HIV and Related Infectious Diseases Research
The global HIV epidemic continues to grow in certain regions while contracting in others, necessitating a broadened research agenda, including clinical pharmacology of tuberculosis, hepatitis, malaria, and immune activation/inflammation, underscoring the need for a coordinated quality assurance approach. A comprehensive program has been developed and implemented by the University at Buffalo HIV Clinical Pharmacology Quality Assurance and Quality Control Program, funded by the National Institutes of Health.
DiFrancesco, R., Tooley, K., Rosenkranz, SL., Siminski, S., Taylor, CR., Pande, P., & Morse, GD. (2013). Clinical Pharmacology Quality Assurance for HIV and Related Infectious Diseases Research. Clinical Pharmacology and Therapeutics, 93(6), 479-482. DOI: 10.1038/clpt.2013.62